Customs and Border Protection (CBP) has issued operational guidance regarding the reduction of additional ad valorem duty rates from 10% to 0% for patented pharmaceuticals and related ingredients originating from the United Kingdom. This adjustment is enacted pursuant to Presidential Proclamation 11020, taking effect for goods entered for consumption, or withdrawn from warehouse for consumption, […]
CBP Issues Compliance Guidance for Duty-Free Treatment on U.K. Patented Pharmaceuticals and Ingredients

